Iceland Health Focus
SEE OTHER BRANDS

The best health and wellness news from Iceland

Press Releases

Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Iceland Health Focus.

VIVUS Unveils Global Initiative to Advance Healthy and Sustainable Weight Management

VIVUS Unveils Global Initiative to Advance Healthy and Sustainable Weight Management

VIVUS reaffirms commitment to combatting global obesity crisis on World Obesity Day 2025 with VIVUS For Life CAMPBELL, Calif., March 04, 2025 (GLOBE NEWSWIRE) -- VIVUS, LLC., a biopharmaceutical company committed to the development and...

argenx Announces European Commission Approval of VYVGART Subcutaneous Injection for Chronic Inflammatory Demyelinating Polyneuropathy

argenx Announces European Commission Approval of VYVGART Subcutaneous Injection for Chronic Inflammatory Demyelinating Polyneuropathy

VYVGART® SC, first-and-only IgG Fc-antibody fragment which specifically targets the neonatal Fc receptor (FcRn), now approved for use in Europe for CIDP Approval based on ADHERE clinical trial, the largest study of CIDP patients to date First...

Red Cross Field Hospital in Rafah, Gaza Strip: Facts & Figures February 2025

Red Cross Field Hospital in Rafah, Gaza Strip: Facts & Figures February 2025

The Red Cross Field Hospital was established and opened on 9 May 2024, and is implemented in coordination with the Palestine Red Crescent Society and supported by Red Cross Societies of Australia, Austria, Canada, China (Hong Kong branch),...

Arctic Exceptionalism as Myth, Method, and Mirror

Arctic Exceptionalism as Myth, Method, and Mirror

Back to Publications Meteor shower and Northern Lights over Snæfellsnes glacier, Iceland. Photo: Diana Robinson There is a story we tell ourselves about the Arctic. Every Arctic expert knows it by heart. It began in Murmansk, 1987, when Soviet...

Category Intelligence Clinical Trials Market is Projected to Reach USD 106.78 Billion by 2032 | CAGR of 7.1%

Category Intelligence Clinical Trials Market is Projected to Reach USD 106.78 Billion by 2032 | CAGR of 7.1%

CA, UNITED STATES, January 24, 2025 /⁨EINPresswire.com⁩/ -- The clinical trials market is experiencing steady growth, driven by rising demand for innovative therapies across therapeutic areas such as oncology, cardiology, neurology, and infectious...

VIVUS Shares Progress on Pipeline and Key Program Milestones During the 43rd Annual J.P. Morgan Healthcare Conference 2025

VIVUS Shares Progress on Pipeline and Key Program Milestones During the 43rd Annual J.P. Morgan Healthcare Conference 2025

CAMPBELL, Calif., Jan. 13, 2025 (GLOBE NEWSWIRE) -- VIVUS LLC, a biopharmaceutical company committed to the development and commercialization of innovative therapies that focus on advancing treatments for patients with serious unmet medical needs,...

Red Cross Field Hospital in Rafah, Gaza Strip: Facts & Figures December 2024

Red Cross Field Hospital in Rafah, Gaza Strip: Facts & Figures December 2024

A Red Cross and Red Crescent response The Red Cross Field Hospital is implemented in coordination with the Palestine Red Crescent Society and supported by Red Cross Societies of Australia, Austria, Canada, China (Hong Kong branch), Denmark,...

Bionano Recaps Global Momentum Behind Optical Genome Mapping at the 2025 Annual Meeting of the European Society of Human Genetics Held Recently in Milan, Italy

Bionano Recaps Global Momentum Behind Optical Genome Mapping at the 2025 Annual Meeting of the European Society of Human Genetics Held Recently in Milan, Italy

SAN DIEGO, June 18, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics (NASDAQ: BNGO) recently participated in the European Society of Human Genetics (ESHG) conference held in Milan, Italy, from May 24-27, 2025. The event highlighted the use of optical...

Helvetic Clinics Strengthens Its Leadership in Dental Tourism in Hungary in 2024

Helvetic Clinics Strengthens Its Leadership in Dental Tourism in Hungary in 2024

Helvetic Clinics, recognized the best dental clinic in Hungary, continues to set the benchmark for excellence in patient care with a strategic expansion in 2024 BUDAPEST, BUDAPEST, HUNGARY, December 11, 2024 /⁨EINPresswire.com⁩/ -- Helvetic...

The Arctic This Week Take Five: Week of 9 June, 2025

The Arctic This Week Take Five: Week of 9 June, 2025

Back to Publications Quebec Authorities Monitoring Tuberculosis Outbreaks in Nunavik As reported by CBC News on June 10, Quebec’s public health service stated that it is closely monitoring the increasing number of tuberculosis cases in Nunavik....

European Medicines Agency Confirms Acceptance of Marketing Authorization Application for AVT05, a Proposed Biosimilar to Simponi® (golimumab)

European Medicines Agency Confirms Acceptance of Marketing Authorization Application for AVT05, a Proposed Biosimilar to Simponi® (golimumab)

REYKJAVIK, Iceland and LONDON, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and Advanz Pharma, a UK...

Alvotech Attending Citi's Global Healthcare Conference on December 4, 2024, and Evercore’s HealthCONx Conference on December 5, 2024

Alvotech Attending Citi's Global Healthcare Conference on December 4, 2024, and Evercore’s HealthCONx Conference on December 5, 2024

REYKJAVIK, Iceland, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today its participation in Citi’s...

Alvotech’s Private Placement Completed with Delivery of SDRs and Shares to Investors

Alvotech’s Private Placement Completed with Delivery of SDRs and Shares to Investors

Alvotech (NASDAQ: ALVO, ALVO-SDB, the “Company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the completion of a private placement that was carried out...

Oculis to Present at the Stifel 2024 Healthcare Conference

Oculis to Present at the Stifel 2024 Healthcare Conference

ZUG, Switzerland, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS) (“Oculis”), a global biopharmaceutical company purposefully driven to save sight and improve eye care, today announced that Oculis’ management will be present at...

Alvotech Meeting Investors and Presenting at the Jefferies 2024 London Healthcare Conference on November 19–20, 2024

Alvotech Meeting Investors and Presenting at the Jefferies 2024 London Healthcare Conference on November 19–20, 2024

REYKJAVIK, Iceland, Oct. 25, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today its participation in the...

'SELLING SUPERMAN' PREMIERES DIGITALLY NOV 18, A HEARTFELT TALE OF COMIC LEGACY, FAMILY, MENTAL HEALTH, AND REDEMPTION

'SELLING SUPERMAN' PREMIERES DIGITALLY NOV 18, A HEARTFELT TALE OF COMIC LEGACY, FAMILY, MENTAL HEALTH, AND REDEMPTION

Comic Book Fans and Documentary Lovers Get the Ultimate Gift This Fall LOS ANGELES, CA, UNITED STATES, November 14, 2024 /⁨EINPresswire.com⁩/ -- On November 18, the highly anticipated four-part documentary series, SELLING SUPERMAN, will be...

Seaweed Market Worth Observing Growth Rate of 9.5% from 2025 to 2034 | Annie Chun's, Inc., Brandt, Inc., Cargill

Seaweed Market Worth Observing Growth Rate of 9.5% from 2025 to 2034 | Annie Chun's, Inc., Brandt, Inc., Cargill

WILMINGTON, DE, UNITED STATES, June 17, 2025 /⁨EINPresswire.com⁩/ -- The seaweed market size was valued at $7.5 billion in 2024, and is estimated to reach $18.1 billion by 2034, growing at a CAGR of 9.5% from 2025 to 2034. Seaweed is a diverse...

European Medicines Agency Confirms Acceptance of Marketing Application for AVT03, a Proposed Biosimilar to Prolia® and Xgeva®

European Medicines Agency Confirms Acceptance of Marketing Application for AVT03, a Proposed Biosimilar to Prolia® and Xgeva®

REYKJAVIK, Iceland, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today that the European Medicines...

VIVUS Announces Commercialization of QSIVA® in Sweden, Denmark, Finland, Iceland, Norway, and Poland

VIVUS Announces Commercialization of QSIVA® in Sweden, Denmark, Finland, Iceland, Norway, and Poland

AMSTERDAM, Oct. 07, 2024 (GLOBE NEWSWIRE) -- VIVUS BV, a subsidiary of VIVUS LLC, today announced the availability of QSIVA® (phentermine and topiramate modified-release) in Sweden, Denmark, Finland, Iceland, Norway, and Poland, making QSIVA...

As Per TNR, The Niche Research, Global Mobile Medical Imaging Market is Expected to Grow at a CAGR of 7.6% from 2024 to 2034, Covering Various Product Type, Imaging Technology, Application, End User and Regions

As Per TNR, The Niche Research, Global Mobile Medical Imaging Market is Expected to Grow at a CAGR of 7.6% from 2024 to 2034, Covering Various Product Type, Imaging Technology, Application, End User and Regions

Wilmington, Delaware, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Mobile medical imaging refers to the use of portable imaging devices that allow healthcare professionals to perform diagnostic imaging at the point of care. This technology includes equipment...

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service